
FOLLOWUS
1. The First Affiliated Hospital to Nanhua University,Hengyang,China
2. The Second Hospital of Xiangya, Zhongnan University,China
3. Biochemistry and Bio-technology Experimental Center, Nanhua University,China
Published:2004,
Scan for full text
Jiang-hua, L., Shi-fang, D., Zhi-wen, L. et al. Study of Tripterygium associated with nicotinamide in treating late-onset autoimmune diabetes mellitus in adults., Chin. J. Integr. Med. 10, 193–196 (2004). https://doi.org/10.1007/BF02836406
Liu Jiang-hua, Duan Shi-fang, Liu Zhi-wen, et al. Study of Tripterygium associated with nicotinamide in treating late-onset autoimmune diabetes mellitus in adults. [J]. Chinese Journal of Integrative Medicine 10(3):193-196(2004)
Jiang-hua, L., Shi-fang, D., Zhi-wen, L. et al. Study of Tripterygium associated with nicotinamide in treating late-onset autoimmune diabetes mellitus in adults., Chin. J. Integr. Med. 10, 193–196 (2004). https://doi.org/10.1007/BF02836406 DOI:
Liu Jiang-hua, Duan Shi-fang, Liu Zhi-wen, et al. Study of Tripterygium associated with nicotinamide in treating late-onset autoimmune diabetes mellitus in adults. [J]. Chinese Journal of Integrative Medicine 10(3):193-196(2004) DOI: 10.1007/BF02836406.
Objective: To explore the effect of Tripterygium polyglycoside (TP) associated with nicotinamide on the islet cell function
immune parameters and lipoperoxide (LPO) in adult patients with late-onset autoimmune diabetes mellitus (LADA).Methods: Thirty-six cases of LADA were randomly divided into three groups: TP group (n = 12)
treated with TP plus orally taken metformin; combined treatment group (n = 12)
treated with TP combined with nicotinamide and metformin
and control group (n = 12) treated with metformin alone. They were followed-up for 18 months.Results: (1) Compared with the control group after 9 months of treatment
postprandial plasma glucose and LPO in combined treatment group were decreased (P <0.05)
and the postprandial C-peptide was higher (P<0.05). At the 18th month
the value of postprandial C-peptide in the TP and combined treatment group was higher than that in the control group. The slL-2R level of both TP and combined treatment groups were lowered (P<0.01); (2) Islet cell antibody (ICA) positive of 5 cases in the TP group and 6 cases in the combined treatment group got converted to the negative respectively
while only one in the control group at the time (P<0.05); (3) The level of LPO in the combined treatment group was significantly lower than that in the TP group at the 18th month of treatment (P<0.05).Conclusion: TP combined with nicotinamide played a role in immunity regulation
decreasing the titer of islet cell antibody and slL-2R
which also reduced the production of LPO and had a tendency to improve islet cell function in early LADA patients.
Objective: To explore the effect of Tripterygium polyglycoside (TP) associated with nicotinamide on the islet cell function
immune parameters and lipoperoxide (LPO) in adult patients with late-onset autoimmune diabetes mellitus (LADA).Methods: Thirty-six cases of LADA were randomly divided into three groups: TP group (n = 12)
treated with TP plus orally taken metformin; combined treatment group (n = 12)
treated with TP combined with nicotinamide and metformin
and control group (n = 12) treated with metformin alone. They were followed-up for 18 months.Results: (1) Compared with the control group after 9 months of treatment
postprandial plasma glucose and LPO in combined treatment group were decreased (P <0.05)
and the postprandial C-peptide was higher (P<0.05). At the 18th month
the value of postprandial C-peptide in the TP and combined treatment group was higher than that in the control group. The slL-2R level of both TP and combined treatment groups were lowered (P<0.01); (2) Islet cell antibody (ICA) positive of 5 cases in the TP group and 6 cases in the combined treatment group got converted to the negative respectively
while only one in the control group at the time (P<0.05); (3) The level of LPO in the combined treatment group was significantly lower than that in the TP group at the 18th month of treatment (P<0.05).Conclusion: TP combined with nicotinamide played a role in immunity regulation
decreasing the titer of islet cell antibody and slL-2R
which also reduced the production of LPO and had a tendency to improve islet cell function in early LADA patients.
late-onset autoimmune diabetes mellitus in adultsTripterygiumnicotinamide
late-onset autoimmune diabetes mellitus in adultsTripterygiumnicotinamide
Lohmann T, Rotger J, Seissler J, et al. Distinct genetic and immunological features in patients with onset of ID-DM before and after age 40. Diabetes Care 1997; 20: 524–529.
Carla J, Leomard C. Guidelines for intervention trials in subjects with newly diagnosed type-1 diabetes. Diabetes2003;52: 1059–1062.
Fillipo G, Carel JL, BiotardC. Long-term results of early cyclosporin therapy in juvenile IDDM. Diabetes 1996; 45: 101.
Zhang XZ, Li Q, Wu XZ, et al. Effect of Tripterygium polysaccharide in islet transplantation in treating type 1 diabetes mellitus. Chin Integr Tradit West Med 1994; 14 (8): 451.
Pozzli P, Browne P, Kolb H. Meta-analysis of nicotinam-ide treatment in patients with recent-onset IDDM. Diabe-tes Care 1996;19: 1357.
Wang H. Possibility of preventing type-1 diabetes melli-tus. Clin J Endocrinol Metab 2001; 17(1): 5–6.
Ouyang L, Zhou ZG, Peng J, et al. Preliminary clinical study on Tripteygium intervention in LADA patients. Chin J Diabetes 2000;8(1): 7–9.
0
Views
381
Downloads
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621